Yahoo Finance ArQule (ARQL) in Focus: Stock Moves 15.6% Higher
ArQule, Inc. ARQL was a big mover last session, as the company saw its shares rise nearly 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.65–$1.84 in the past one-month time frame, witnessed a sharp increase yesterday.
Although ArQule has seen no estimate revisions over the past two months, the Zacks Consensus Estimate for the current quarter has also revised downward over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.
ArQule currently has a Zacks Rank #3 (Hold) while its Earnings ESPis negative.
ArQule, Inc. Price and Consensus
ArQule, Inc. Price and Consensus | ArQule, Inc. Quote
A better ranked stock worth considering in the Medical - Drugs industry is Enanta Pharmaceuticals, Inc. ENTA which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is ARQL going up? Or down? Predict to see what others think: Up or Down
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Enanta Pharmaceuticals, Inc. (ENTA) : Free Stock Analysis Report
ArQule, Inc. (ARQL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
